Share

AXA SA (CS.PAR) AI OPINIONS & ADVISOR ANALYSIS

Read and compare the 14 individual AI Advisor deep-dive reports, including their forecast paths, ratings, price targets, and reasoning.

Updated on 20 September 2026Deep analysis 20 September 2026

Publisher

Russlan Ramdowar

25 min readAudit All Past Forecasts

14 AI Advisor Reports

Select an advisor report.

SynthesizerCombines all advisor views

Synthesis of 14 independent opinions

Diversity of ModelsSame approach, varied models

Diversity of FrameworksDifferent investing styles

AI Researcher

Opus 5

Universal Investor AI

The Polymath Framework

Model rating

Buy

5-Year Return Est.

+69.0%

Includes 3.95% annual net dividend contribution

1. Investment Thesis — Base Case

The central tension is that AXA is an excellent, boringly profitable insurer priced as a French political liability. Management's 2027-2029 plan promises 7-9% EPS growth and a 75% payout, but roughly a point and a half of that growth is arithmetic from share cancellation rather than underwriting progress, arriving precisely as commercial rates soften [2][5]. The base case therefore assumes delivery near the low end: mid-single-digit per-share earnings compounding, a holding around 91%, and a multiple that stays where it is rather than re-rating. Investors are paid to wait, and the waiting is the return.

2026E underlying EPS near EUR 4.17 compounding at 6-7% reaches roughly EUR 5.7 by 2030E.
Holding 10.5-11 times underlying earnings implies a quoted price near EUR 61-62 by late 2031.
EUR 25 billion of planned 2027-2029 cash upstream equals about 27% of today's EUR 91 billion capitalisation.

Historical prices and published forecast

Observed price
Published advisor forecast

Observed prices and the selected advisor's published projection share a split-adjusted price basis. Prices after the forecast start are later observations, not information known at publication. Forecasts are uncertain. Values in EUR.

View chart values

Historical prices and published forecast — published chart values
Series	Date	Value (EUR)
Observed price	2021-09-15	23.3
Observed price	2021-09-19	22.6
Observed price	2021-10-01	24.0
Observed price	2021-10-17	23.9
Observed price	2021-10-29	24.6
Observed price	2021-11-14	25.8
Observed price	2021-11-18	25.4
Observed price	2021-11-30	24.7
Observed price	2021-12-08	25.6
Observed price	2021-12-20	25.4
Observed price	2022-01-09	27.4
Observed price	2022-01-17	28.5
Observed price	2022-01-25	27.3
Observed price	2022-02-10	28.6
Observed price	2022-02-26	24.4
Observed price	2022-03-06	22.5
Observed price	2022-03-22	25.6
Observed price	2022-04-07	25.7
Observed price	2022-04-15	27.0
Observed price	2022-04-19	27.1
Observed price	2022-05-09	22.6
Observed price	2022-05-13	22.8
Observed price	2022-05-29	24.1
Observed price	2022-06-06	23.6
Observed price	2022-06-26	22.0
Observed price	2022-06-30	21.9
Observed price	2022-07-04	20.7
Observed price	2022-07-24	21.4
Observed price	2022-08-13	24.5
Observed price	2022-08-17	24.5
Observed price	2022-09-02	23.4
Observed price	2022-09-14	25.4
Observed price	2022-09-30	22.3
Observed price	2022-10-04	22.8
Observed price	2022-10-24	24.8
Observed price	2022-10-28	25.0
Observed price	2022-11-17	26.9
Observed price	2022-12-03	27.4
Observed price	2022-12-11	27.0
Observed price	2022-12-19	26.3
Observed price	2023-01-04	27.1
Observed price	2023-01-08	27.4
Observed price	2023-01-28	28.6
Observed price	2023-02-09	28.7
Observed price	2023-02-21	28.1
Observed price	2023-03-09	30.1
Observed price	2023-03-17	26.0
Observed price	2023-03-25	27.1
Observed price	2023-04-10	29.0
Observed price	2023-04-14	28.7
Observed price	2023-04-22	29.3
Observed price	2023-05-08	27.9
Observed price	2023-05-12	27.1
Observed price	2023-06-05	27.3
Observed price	2023-06-21	26.2
Observed price	2023-07-03	27.0
Observed price	2023-07-07	25.4
Observed price	2023-07-19	27.0
Observed price	2023-07-27	27.9
Observed price	2023-08-20	27.3
Observed price	2023-08-28	27.8
Observed price	2023-09-05	27.7
Observed price	2023-09-17	29.1
Observed price	2023-10-03	27.4
Observed price	2023-10-11	28.3
Observed price	2023-10-23	27.3
Observed price	2023-10-31	28.1
Observed price	2023-11-16	28.1
Observed price	2023-12-06	29.6
Observed price	2023-12-10	30.0
Observed price	2023-12-18	29.3
Observed price	2024-01-11	29.2
Observed price	2024-01-23	30.6
Observed price	2024-01-31	31.2
Observed price	2024-02-08	30.1
Observed price	2024-02-20	31.2
Observed price	2024-03-11	33.3
Observed price	2024-03-15	34.3
Observed price	2024-04-04	34.9
Observed price	2024-04-08	34.3
Observed price	2024-04-16	33.2
Observed price	2024-05-02	31.8
Observed price	2024-05-18	33.7
Observed price	2024-05-26	33.6
Observed price	2024-06-15	29.7
Observed price	2024-06-27	30.6
Observed price	2024-07-05	32.1
Observed price	2024-07-29	32.6
Observed price	2024-08-02	31.7
Observed price	2024-08-06	31.7
Observed price	2024-08-26	34.0
Observed price	2024-08-30	34.4
Observed price	2024-09-19	36.1
Observed price	2024-09-23	36.2
Observed price	2024-10-05	34.4
Observed price	2024-10-17	35.9
Observed price	2024-11-06	34.3
Observed price	2024-11-10	34.2
Observed price	2024-11-30	32.8
Observed price	2024-12-04	33.0
Observed price	2024-12-08	34.0
Observed price	2025-01-13	33.5
Observed price	2025-01-17	35.4
Observed price	2025-01-21	35.3
Observed price	2025-02-10	37.7
Observed price	2025-02-22	37.0
Observed price	2025-03-06	38.6
Observed price	2025-03-10	38.5
Observed price	2025-03-26	40.1
Observed price	2025-04-07	35.2
Observed price	2025-04-23	40.3
Observed price	2025-05-01	42.0
Observed price	2025-05-13	40.7
Observed price	2025-05-29	41.3
Observed price	2025-06-06	42.5
Observed price	2025-06-26	41.9
Observed price	2025-06-30	41.3
Observed price	2025-07-16	41.5
Observed price	2025-07-28	42.4
Observed price	2025-08-05	40.4
Observed price	2025-08-21	43.0
Observed price	2025-09-02	39.6
Observed price	2025-09-14	40.4
Observed price	2025-09-30	40.6
Observed price	2025-10-08	39.5
Observed price	2025-10-16	39.8
Observed price	2025-11-01	37.7
Observed price	2025-11-05	37.8
Observed price	2025-11-13	38.5
Observed price	2025-12-03	38.6
Observed price	2025-12-19	40.9
Observed price	2025-12-27	41.1
Observed price	2026-01-12	39.8
Observed price	2026-01-28	38.1
Observed price	2026-02-05	39.5
Observed price	2026-02-13	37.5
Observed price	2026-03-01	40.2
Observed price	2026-03-09	37.5
Observed price	2026-03-17	39.2
Observed price	2026-03-29	38.5
Observed price	2026-04-18	42.3
Observed price	2026-04-22	41.4
Observed price	2026-05-12	39.2
Observed price	2026-05-16	39.5
Observed price	2026-05-24	40.4
Observed price	2026-06-09	40.1
Observed price	2026-06-29	43.7
Observed price	2026-07-03	43.7
Observed price	2026-07-19	44.8
Observed price	2026-07-27	45.2
Observed price	2026-08-04	44.6
Observed price	2026-09-05	44.5
Observed price	2026-09-09	42.9
Observed price	2026-09-17	45.1
Observed price	2026-09-23	43.2
Observed price	2026-09-25	44.0
Published advisor forecast	2026-09-18	44.7
Published advisor forecast	2026-12-18	46.1
Published advisor forecast	2027-03-18	47.9
Published advisor forecast	2027-06-18	46.0
Published advisor forecast	2027-09-18	48.3
Published advisor forecast	2027-12-18	49.3
Published advisor forecast	2028-03-18	51.2
Published advisor forecast	2028-06-18	50.2
Published advisor forecast	2028-09-18	52.2
Published advisor forecast	2028-12-18	53.3
Published advisor forecast	2029-03-18	54.9
Published advisor forecast	2029-06-18	53.8
Published advisor forecast	2029-09-18	55.4
Published advisor forecast	2029-12-18	56.5
Published advisor forecast	2030-03-18	58.2
Published advisor forecast	2030-06-18	57.0
Published advisor forecast	2030-09-18	58.7
Published advisor forecast	2030-12-18	59.9
Published advisor forecast	2031-03-18	61.7
Published advisor forecast	2031-06-18	60.5
Published advisor forecast	2031-09-18	62.3

2. Scenarios & Signals

Bull case

The bull case activates when French politics stops being the story. A 2027 election delivering credible consolidation compresses the OAT-Bund spread, lifting both solvency and the multiple; the Solvency II revision then releases roughly EUR 4 billion of headroom into a special repurchase that accelerates per-share earnings [11]. AI savings of EUR 500-700 million land on schedule, defending the combined ratio through the soft cycle. Earnings reach the top of the 7-9% range at 12-13 times, and the shares approach EUR 80.

Bear case

The bear case begins with two things breaking together: a French fiscal accident and a casualty reserve charge. Widening OAT spreads erode own funds precisely when AXA XL strengthens US liability reserves, forcing the buyback to be suspended to defend solvency. Losing the repurchase removes the arithmetic core of just as soft commercial pricing pushes the above 94%. The distribution narrative that supports the valuation collapses, and the shares de-rate toward EUR 33-35.

Current crowd narrative

The consensus treats AXA as a bond proxy with an insurance licence: a 6.6% cash-return yield, a mean twelve-month target of EUR 51.93, and a strategic plan whose 7-9% target Berenberg had pre-announced days earlier [6][20]. Shares slipped on plan day, revealing the anchoring bias: investors assume delivery is already paid for and that French sovereign risk caps the multiple permanently.

Alpha-gap assessment

The crowd modestly underestimates these shares, but the decisive evidence is forensic rather than strategic. AXA reports half-yearly, so mechanically summed trailing data double-counts: the supplied 5.17x P/E and 36.8% free cash flow yield are artifacts, not valuations. Correctly computed, the stock trades near 10.7 times 2026E underlying of roughly EUR 4.17 with 17 points of half-yearly operating solvency generation against 12 points of distribution [9]. The blind spot is that the French domicile discount is treated as structural when it is election-dated.

Convergence catalyst

The 2027 French presidential outcome and the subsequent budget are the trigger. A consolidation-credible result compresses the OAT-Bund spread and removes the domicile penalty applied to a group earning most profit outside France. First observable sign: AXA outperforming Allianz on days when OATs rally.

Macro-regime alignment

The wind is mostly at its back. Higher-for-longer policy rates, with the Fed at 3.75%-4.00% and the ECB at 2.50%, lift reinvestment yields across a bond-heavy balance sheet faster than they raise AXA's own refinancing cost. The offsetting channel is sovereign: French spread widening damages own funds and the multiple simultaneously, making the thesis more sensitive to fiscal politics than to growth.

Paywalled preview begins: Macro-regime alignment

From this section to the end-of-preview notice below, research is provided as simplified HTML text and tables. Full access provides the complete interactive interface, charts and additional datasets.

Sentiment and regime

Greed and fear sentiment: -0.1
Expected volatility regime: moderate
Convergence-cycle position: growing_awareness

Primary drivers

Primary drivers supplied in this advisor's published forecast
Force	Rationale	Probability	Expected price impact
THE Buyback Flywheel Shrinks THE Float	AXA committed on 15 September 2026 to distribute 75% of underlying EPS, combining a rising dividend with an annual repurchase of at least EUR 1.25 billion on a roughly EUR 91 billion capitalisation [2][3]. Cancellation of repurchased shares converts flat group earnings into rising per-share earnings, mechanically adding over one point to the 7-9% EPS CAGR target. With EUR 25 billion of planned organic cash upstream for 2027-2029, the mechanism is funded and persistent.	Not available	+18.0%
Float Earns ITS KEEP Again	The Fed at 3.75%-4.00% and ten-year OATs above 4.1% mean AXA reinvests maturing bonds well above legacy book yields [15][16][18]. For a P&C and protection insurer holding several hundred billion of invested assets, each maturity roll lifts recurring investment income without underwriting risk, cushioning softer commercial pricing. This tailwind persists through the horizon because portfolio duration staggers repricing over years rather than quarters.	Not available	+12.0%
PURE Insurer Capital Light MIX	Selling AXA IM to BNP Paribas on 1 July 2025 removed a sub-scale asset manager and left a technical-risk underwriter [11]. H1 2026 showed the payoff: underlying earnings up 9% excluding AXA IM, with Life and Health up 11% and gross written premiums up 5% to EUR 66.3 billion [7]. Health, protection and direct retail carry lower capital intensity and less cyclicality than large-account commercial lines, stabilising the earnings base investors capitalise.	Not available	+8.0%
AI AS AN Expense Ratio Weapon	Management quantified AI initiatives at EUR 500-700 million of recurring annual value as pilots move into underwriting, claims triage and distribution [5]. Against roughly EUR 8.6 billion of 2026 underlying earnings, that is a 6-8% uplift available without premium growth, and it lands precisely where a softening rate cycle squeezes the loss ratio. Delivery risk is real, but scale insurers with proprietary claims data are the natural beneficiaries of this technology.	Not available	+7.0%

Primary frictions

Primary frictions supplied in this advisor's published forecast
Force	Rationale	Probability	Expected price impact
THE Commercial Cycle Turns Downward	The H1 2026 P&C combined ratio of 90.1% was ten basis points worse than a year earlier: the margin has plateaued [8]. Executives themselves cite falling commercial rates and a pivot toward retention, direct and health [5], and management's new 15-17% ROE target sits below the 18.3% already printed, which reads as pre-signalled normalisation. Softening large-account pricing at AXA XL compresses underwriting profit for several years before the cycle turns.	Not available	-12.0%
Paris Domicile Permanent Discount	AXA is a French national champion priced through a French sovereign lens. The OAT-Bund spread widened to roughly 85 basis points by late August 2026 from 55 at the start of the year, with Scope downgrading France to A+ and Moody's outlook negative [15][17]. Widening government spreads already produced an unfavourable CSM market impact in H1 [10]. Until the 2027 budget and election resolve, this caps the multiple investors pay.	Not available	-9.0%
Weather Bills Arrive Annually NOW	AXA's own 2026 guidance is explicitly conditional on a normalised natural-catastrophe load [4]. Secondary perils, European flood and convective storm frequency, and wildfire exposure at AXA XL have made the catastrophe budget a recurring rather than exceptional charge, while reinsurance retentions have risen industry-wide. Each above-budget year consumes underlying earnings and the buyback capacity that funds per-share growth, and the trend is structural rather than cyclical.	Not available	-7.0%
Grandfathering ENDS Coupons Reset	The Solvency II ratio fell from 224% at year-end 2025 to 218% at 30 June 2026 chiefly because grandfathering ended for certain subordinated debt, a ten-point hit [9]. Replacement capital must be issued at today's yields rather than the 2-3% coupons of the last decade, raising financing costs against a gearing ratio of 21.7%. This is a slow, contractual drag on distributable earnings across the refinancing schedule.	Not available	-5.0%

Tail opportunities

Tail opportunities supplied in this advisor's published forecast
Force	Rationale	Probability	Expected price impact
France DE Risks THE Discount Lifts	A 2027 presidential outcome delivering credible fiscal consolidation would compress the OAT-Bund spread back toward 50 basis points, removing the sovereign penalty applied to French financials [15][18]. AXA at roughly 10.7 times underlying earnings would re-rate toward the 12-13 times commanded by Zurich and Allianz peers, worth around a fifth on the quoted price with no change in operating delivery. Expect the move in the second half of 2027. It remains below 50% because French budget arithmetic has defeated three successive governments.	30.0%	+20.0%
Solvency II Revision Unlocks A Special	AXA guided to an expected +17 point impact from the Solvency II revision [11]. Applied to a EUR 25.8 billion SCR, that is roughly EUR 4.4 billion of additional coverage, enough to fund a special repurchase of about 5% of the float or a bolt-on health acquisition in Asia or Europe. The likely window is 2027-2028 once the legal application date is fixed. It stays below 50% because the timing is unverified, and management may bank headroom against sovereign volatility rather than distribute it.	38.0%	+14.0%

Tail risks

Tail risks supplied in this advisor's published forecast
Force	Rationale	Probability	Expected price impact
OAT Spread Becomes A Solvency Event	A disorderly French fiscal episode, triggered by a failed 2027 budget or an election result hostile to consolidation, would push the OAT-Bund spread beyond 150 basis points and force a further rating downgrade. AXA holds large French sovereign and domestic credit exposure; widening spreads already dented CSM in H1 2026 [10]. Solvency would fall, the buyback would be paused to protect the ratio, and the equity would de-rate hard. Probability stays below 50% because insurers hold sovereigns to maturity against matched liabilities, limiting realised losses.	30.0%	-22.0%
US Casualty Reserves Crack OPEN	Social inflation in US liability lines has forced repeated reserve strengthening across the London and Bermuda market. If AXA XL's 2016-2021 casualty accident years prove deficient, a multi-billion euro charge in any year through 2029 would break the 15-17% ROE target, consume a year of buyback capacity and destroy confidence in the 90% combined ratio. My sources do not verify AXA's current reserve development, which is the gap. It remains below 50% because AXA reduced US casualty limits materially after 2019 and reserves screen adequately on disclosed run-off.	24.0%	-18.0%

Step-by-step forecast path

Universal Investor forecast path for prediction task predrqst_batch_task__xrefsubjtskconf_3804c3eb-8793-5b40-b9fe-3387f9f0981f__sb7__20260920064920277661
Step	Forecast date	Step change	Projected value (EUR)	Scenario rationale
1	December 18, 2026	+3.0%	46.07	Q3 activity indicators on 28 October confirm the plan's EUR 8.6 billion starting point. Year-end value rotation rewards a genuine 6.6% cash-return yield even as the Fed's 4.00% ceiling lifts the discount rate.
2	March 18, 2027	+4.0%	47.91	February FY2026 results print underlying EPS near EUR 4.17, an eighth consecutive dividend increase and a renewed repurchase authorisation. Capital-return credibility outweighs early evidence of softening large-account commercial property pricing.
3	June 18, 2027	-4.0%	46.00	April's French presidential election widens OAT-Bund spreads and pressures domestic financials, coinciding with the annual ex-dividend of roughly EUR 2.50 per share. Both effects strike the quoted price directly and simultaneously.
4	September 18, 2027	+5.0%	48.30	Post-election fiscal clarity compresses the sovereign risk premium embedded in French financials. H1 2027 results show plan year one tracking inside the 7-9% EPS band, while cancelled shares lift per-share arithmetic.
5	December 18, 2027	+2.0%	49.26	Softer January renewal expectations cap enthusiasm in commercial lines, but reinvestment of maturing bonds above legacy book yields lifts recurring investment income. Net effect is modest drift with subdued realised volatility.
6	March 18, 2028	+4.0%	51.23	FY2027 results confirm underlying ROE inside the 15-17% band and cash upstream tracking toward EUR 25 billion. Solvency II revision headroom supports an enlarged repurchase authorisation alongside the dividend increase.
7	June 18, 2028	-2.0%	50.21	The annual ex-dividend mechanically removes roughly five percent of price. Continued share cancellation and accruing first-half earnings recover most of it within the window, leaving a small net decline.
8	September 18, 2028	+4.0%	52.22	H1 2028 shows health and protection growth offsetting soft large-commercial rates. European policy easing begins as inflation normalises, lifting insurer valuations while portfolio reinvestment yields still exceed maturing book yields.
9	December 18, 2028	+2.0%	53.26	A normalised catastrophe year and visible early AI expense savings hold the combined ratio near 91%. Price drifts with earnings accrual; no re-rating, as the French domicile discount persists.
10	March 18, 2029	+3.0%	54.86	FY2028 results deliver the middle plan year with dividend growth near 7% and the buyback renewed. Private credit reallocation contributes incremental spread income without a visible credit-loss event.
11	June 18, 2029	-2.0%	53.76	Ex-dividend detachment again dominates the quarter. Soft commercial pricing at AXA XL keeps underwriting profit flat, so earnings accrual only partially offsets the mechanical distribution drag.
12	September 18, 2029	+3.0%	55.38	H1 2029 confirms EPS compounding near the lower half of the 7-9% target. Attention turns to the successor strategic plan due in 2029, with speculation about a larger distribution commitment.
13	December 18, 2029	+2.0%	56.48	A lower-rate European environment modestly compresses new-money yields but supports equity valuations generally. AXA trades as a defensive income compounder, drifting higher on buyback accretion alone.
14	March 18, 2030	+3.0%	58.18	Final plan-year results close the 2027-2029 period near target, validating management credibility. A successor plan preview extends the payout framework, sustaining the distribution narrative that anchors the multiple.
15	June 18, 2030	-2.0%	57.01	Annual dividend detachment repeats, now on a larger per-share amount. Underwriting cycle conditions remain soft, limiting the earnings accrual available to offset the payment within the quarter.
16	September 18, 2030	+3.0%	58.73	H1 2030 shows AI-enabled claims and underwriting savings fully embedded in the expense ratio, offsetting rate softness. Investors credit structural efficiency rather than cyclical luck for the margin defence.
17	December 18, 2030	+2.0%	59.90	Commercial pricing shows early signs of bottoming after several soft years, improving forward underwriting expectations. Price advances modestly as the cumulative share count reduction compounds per-share earnings.
18	March 18, 2031	+3.0%	61.70	FY2030 results confirm the new plan's first year on track, with book value per share compounding at a mid-teens rate inclusive of dividends. Buyback renewal is treated as routine.
19	June 18, 2031	-2.0%	60.46	The familiar ex-dividend mechanic reasserts itself. With roughly a fifth of the original share count retired since 2026, per-share distributions are materially larger, deepening the detachment effect.
20	September 18, 2031	+3.0%	62.28	A hardening pricing cycle begins to lift forward combined-ratio expectations as capacity discipline returns. AXA ends the horizon near EUR 62, roughly 39% above anchor, with dividends paid on top.

Advisor and configuration

Advisor: universal_investor__the_polymath__anthropic_claude_opus_5__20260724_release
Persona: Universal Investor
Archetype: The Polymath
Model: 2026-07-24 release
Provider: Anthropic
Mode: RESEARCHER (Web Search Enabled) with High Reasoning and Standard Creativity
Task configuration: universal_investor__the_polymath__anthropic_claude_opus_5__20260724_release__equity__json__extnd_invest_thesis_4q_alphassym__ts_num_desc__h5y_s3m__var1__researcher__standard_creativity_high_thinking__batch
Forecast horizon: 5 year
Forecast steps: 20 steps of 3 month
Assembly type: Balanced Assembly
Assembly name: universal_investor__the_polymath__anthropic_claude_opus_5__20260724_release RESEARCHER Forecast Assembly
Input format: inmemory_base_placeholders__latest_eod_close_price_with_stats_and_fundamentals__var1
Output format: Equity Extended Investment Thesis (4 Quadrants and Alpha Asymmetry) + Pct Change Timeseries for Close Price with Rationale, (5Y Quarterly)

Read the complete Universal Investor advisor methodology

Configuration components

aiassmprmtcmpnt_b995bbe2-6a15-55be-a576-525904f696e8
aiassmprmtcmpnt_c55d1851-d218-5d30-b83b-54bbda31e2ee
aiassmprmtcmpnt_930157b1-05d7-5699-bf0a-738645ee42fd
aiassmprmtcmpnt_3c0c459a-0d4a-50ca-87df-c172ec5618aa
aiassmprmtcmpnt_8115cc2a-d418-54b1-a616-49dfa91195f4

Research sources

[1]AXA SA (AXA:CA) Discusses New Strategic Plan and Growth Initiatives for 2027-2029 Transcript | Seeking Alphaseekingalpha.com
[2]AXA (EPA:CS) |finanzwire.com
[3]AXA targets 7-9% earnings growth through 2029 in new strategic plan By Investing.comca.investing.com
[4]AXA announces its 2027-2029 strategy and financial targets | AXAaxa.com
[5]Axa leans on AI and direct sales for growth in softening market, executives say | The Insurertheinsurer.com
[6]AXA stock gains as Investor Day nears on back of strong half-year 2026 figuresad-hoc-news.de
[7]Half Year 2026 Earnings - On track to deliver “Unlock the Future” plan targets | AXAaxa.com
[8]Earnings call transcript: AXA posts strong H1 2026 growth, shares little changed By Investing.comm.investing.com
[9]AXA H1 2026 slides: 8% EPS growth, strong capital position By Investing.cominvesting.com
[10]AXA (EPA:CS) |webdisclosure.com
[11]Full Year 2025 Earnings | AXAaxa.com
[12]AXA (EPA:CS) | AXA Initiates €1.25 Billion Share Buyback Programwebdisclosure.com
[13]Execution of a share repurchase agreement in relation to AXA’s share buy-back program of up to Euro 1.25 billion | AXAaxa.com
[14]How AXA’s 2026 Buyback, Higher Dividend and Earnings Jump At AXA (ENXTPA:CS) Has Changed Its Investment Story - Simply Wall St Newssimplywall.st
[15]France OATs and Fiscal Policy 2026 | Amundi Research Centerresearch-center.amundi.com
[16]OAT / Bund spread today: 84.7 bps as of Sep 4, 2026ideal-investisseur.fr
[17]Scope downgrades France’s long-term ratings to A+ and revises the outlooks to stable | Newsquawknewsquawk.com
[18]France is becoming the ‘poster child’ of sovereign debt problems as government borrowing costs hit near 2008 highscnbc.com
[19]AXA stock trades near recent highs as new employee share plan launchesad-hoc-news.de
[20]AXA stock edges lower as BofA adjusts target and strategy plan stays in focusad-hoc-news.de
[21]AXA stock gains as 2027-2029 targets draw fresh supportad-hoc-news.de
[22]AXA S.A. stock faces pressure amid European insurance sector volatilityad-hoc-news.de
[23]AXA Dividend 2026 & forecast 2027 2028 2029 | ex-daystocksguide.com
[24]AXA: share buyback program of up to E1.2bn -March 03, 2025 at 02:04 am ESTmarketscreener.com

Back to advisor navigation

End of the paywalled preview

The excerpt from Macro-regime alignment to this notice is the simplified paywalled content included on this page. A signed-in, verified account with the required subscription provides the full interactive interface and the additional research, datasets and tools listed below.

Those additional materials are not included in this preview and cannot be revealed by removing its visual restrictions.

Other AI Advisor reports — limited previews

Niccolo Machiavelli — RESEARCHER (Web Search Enabled) with High Reasoning and Standard Creativity

Gemini 3.8 Flash

Limited structural preview, provided as simplified HTML. The complete report contains substantially more research: its investment thesis; bull and bear scenarios; macro-regime analysis; drivers, risks and opportunities; quarterly forecast tables and rationale; references and published configuration. Those findings and datasets are not included here. Sign in with the required subscription to open this advisor's full report.